Prostaglandin-Based Efficacy and Cardiovascular Toxicity Prediction for COX-2 Inhibitors on FAP Prevention by Using an Apc-Mutant Pirc Rat Model
Science360. Yun C. 11/14/17; 197755; T8091
CLICK HERE TO LOGIN
PREMIUM CONTENT
PREMIUM CONTENT
Access to this content is restricted to active members.
Click here to join AAPS or renew your membership.
Click here to join AAPS or renew your membership.
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}